Logo image of ARL

AMERICAN REALTY INVESTORS IN (ARL) Stock Fundamental Analysis

NYSE:ARL - New York Stock Exchange, Inc. - US0291741090 - Common Stock - Currency: USD

12.57  +0.06 (+0.48%)

Fundamental Rating

2

ARL gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 65 industry peers in the Real Estate Management & Development industry. ARL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ARL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ARL had negative earnings in the past year.
In the past year ARL had a positive cash flow from operations.
Of the past 5 years ARL 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: ARL reported negative operating cash flow in multiple years.
ARL Yearly Net Income VS EBIT VS OCF VS FCFARL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

With a Return On Assets value of -1.42%, ARL perfoms like the industry average, outperforming 50.77% of the companies in the same industry.
ARL has a Return On Equity (-2.44%) which is in line with its industry peers.
Industry RankSector Rank
ROA -1.42%
ROE -2.44%
ROIC N/A
ROA(3y)10.05%
ROA(5y)6.32%
ROE(3y)19.68%
ROE(5y)12.84%
ROIC(3y)N/A
ROIC(5y)N/A
ARL Yearly ROA, ROE, ROICARL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

With a decent Gross Margin value of 42.81%, ARL is doing good in the industry, outperforming 76.92% of the companies in the same industry.
In the last couple of years the Gross Margin of ARL has declined.
ARL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.35%
GM growth 5Y-1.62%
ARL Yearly Profit, Operating, Gross MarginsARL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

4

2. Health

2.1 Basic Checks

ARL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ARL remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ARL has more shares outstanding
The debt/assets ratio for ARL is higher compared to a year ago.
ARL Yearly Shares OutstandingARL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ARL Yearly Total Debt VS Total AssetsARL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.13, we must say that ARL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ARL (1.13) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.31 indicates that ARL is not too dependend on debt financing.
ARL has a Debt to Equity ratio (0.31) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 1.13
ROIC/WACCN/A
WACC6.83%
ARL Yearly LT Debt VS Equity VS FCFARL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 3.32 indicates that ARL has no problem at all paying its short term obligations.
ARL's Current ratio of 3.32 is fine compared to the rest of the industry. ARL outperforms 78.46% of its industry peers.
A Quick Ratio of 3.32 indicates that ARL has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.32, ARL belongs to the best of the industry, outperforming 83.08% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.32
Quick Ratio 3.32
ARL Yearly Current Assets VS Current LiabilitesARL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

0

3. Growth

3.1 Past

The earnings per share for ARL have decreased strongly by -481.52% in the last year.
Looking at the last year, ARL shows a decrease in Revenue. The Revenue has decreased by -6.20% in the last year.
The Revenue has been decreasing by -0.29% on average over the past years.
EPS 1Y (TTM)-481.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.39%
Revenue 1Y (TTM)-6.2%
Revenue growth 3Y4.05%
Revenue growth 5Y-0.29%
Sales Q2Q%-14.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ARL Yearly Revenue VS EstimatesARL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ARL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARL Price Earnings VS Forward Price EarningsARL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ARL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 62.54
ARL Per share dataARL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ARL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMERICAN REALTY INVESTORS IN

NYSE:ARL (5/2/2025, 8:04:00 PM)

12.57

+0.06 (+0.48%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)04-07 2025-04-07
Earnings (Next)05-14 2025-05-14
Inst Owners3.26%
Inst Owner Change5.04%
Ins Owners0.22%
Ins Owner Change0%
Market Cap203.01M
Analysts0
Price TargetN/A
Short Float %1.49%
Short Ratio2.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.29
P/FCF N/A
P/OCF 186.41
P/B 0.34
P/tB 0.34
EV/EBITDA 62.54
EPS(TTM)-0.91
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-3.52
FCFYN/A
OCF(TTM)0.07
OCFY0.54%
SpS2.93
BVpS37.26
TBVpS37.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.42%
ROE -2.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.81%
FCFM N/A
ROA(3y)10.05%
ROA(5y)6.32%
ROE(3y)19.68%
ROE(5y)12.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.35%
GM growth 5Y-1.62%
F-Score3
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 31.47
Cap/Depr 462.24%
Cap/Sales 122.43%
Interest Coverage N/A
Cash Conversion 18.48%
Profit Quality N/A
Current Ratio 3.32
Quick Ratio 3.32
Altman-Z 1.13
F-Score3
WACC6.83%
ROIC/WACCN/A
Cap/Depr(3y)243.84%
Cap/Depr(5y)175.89%
Cap/Sales(3y)69.61%
Cap/Sales(5y)51.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-481.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.39%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.2%
Revenue growth 3Y4.05%
Revenue growth 5Y-0.29%
Sales Q2Q%-14.29%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y41.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y103.51%
OCF growth 3YN/A
OCF growth 5YN/A